Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Southwest Oncology Group
ClinicalTrials.gov Identifier:
NCT00003095
First received: November 1, 1999
Last updated: October 23, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2001
  Primary Completion Date: February 2001 (Final data collection date for primary outcome measure)